The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices ...

Treasury Secretary Scott Bessent says he plans to take a “ringside seat” at the U.S. Supreme Court on Wednesday.